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This study was carried out to determine the changes in the urine levels of sodium (Na
+
), potassium (K
+
), 
and calcium (Ca
2+
) of rats during a week of intramuscular administration of artemether (12.5 to 50.0 
mg/kg/day), another one week thereafter and their concentrations in the plasma at the end of the study. 
At 12.5 and 25.0 mg/kg of artemether, urine Na
+
 concentration was significantly increased throughout 
the study (p < 0.05), except on Day 7 (at 12.5 mg/kg) and Day 11 (at 25.0 mg/kg), when it was not 
significantly different from the control. At 12.5 mg/kg of the drug, urine K
+
 concentration was 
significantly increased throughout the study (p < 0.05). Artemether caused no significant changes in 
urine Ca
2+
 concentration in the control rats as well as those that received 12.5 and 25.0 mg/kg of 
artemether. Progressive and significant reductions in the urine concentrations of all the electrolytes at 
50.0 mg/kg of artemether were observed. Their concentrations in the plasma were also significantly 
reduced at this dose of the drug. A dose-dependent degeneration of the renal tissue of all the 
experimental rats was also observed. We concluded that high doses of artemether caused progressive 
degeneration of the renal tissue of rats, inability of the damaged kidneys to concentrate urine, which 
manifested as excessive water loss and electrolyte depletion.  
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INTRODUCTION 
 
Artemether, one of the derivatives of artemisinin, is 
reputed for its efficacy in the treatment of malaria, 
including those resulting from infection by chloroquine-
resistant strains of plasmodium (Qinghaosu antimalarial 
coordinating research group, 1979; China cooperative 
research group on Qinghaosu and its derivatives as anti-
malarials, 1982). Though in combination with other anti-
malarials, it is gaining ground as one of the first lines of 
treatment of cerebral malaria caused by chloroquine-
resistant plasmodium (Van Vugt et al., 1999; Nosten et 
al., 2000).  It has been reported that intramuscular ad-
ministration of multiple doses of the drug to dogs, rats 
and rhesus monkeys produced neurotoxic effects such as 
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gait disturbances, loss of spinal and pain reflexes (Petras 
et al., 1997; Sumalee et al., 1997; Nontprasert et al., 
1998; 2000; Xiao et al., 2002). High doses of artemether 
were also reported to have caused neuronal necrosis in 
the region of the brainstem of rats (Raymond et al., 1998; 
Xiao et al., 2002). Anorexia and a dose-dependent 
reduction in body weight have also been reported at 
these high doses (Qigui et al., 1998). We have studied 
the changes in some of the visceral functions of Wistar 
rats following one week of intramuscular administration of 
12.5 to 50.0 mg/kg of artemether (Akomolafe et al., 
2006). We reported a pattern of anorexia which 
manifested as a significant reduction in the food and 
water intake of all the treated rats. This was accompanied 
by significant increases in their urine output. These 
effects persisted until even one week after the stoppage 
of drug  administration  in  those  rats  that  received  50.0  
 
 
 
 
mg/kg of the drug, whereas those that received lower 
doses had only their food intake restored during this 
period (Akomolafe et al., 2006). We concluded that the 
significant increase in urine output without a corres-
ponding increase in the water intake of the rats could 
exacerbate dehydration and lead to a deleterious effect 
on the ionic balance of the body fluid of the rats 
(Akomolafe et al., 2006). We also postulated that high 
doses of artemether could cause impaired renal function 
of the treated rats and that the significant increase in 
urine output could be due to other effects of the drug on 
thirst, anti-diuretic hormone output and the osmotic 
pressure of their blood (Akomolafe et al., 2006). The 
plasma levels of some electrolytes namely sodium (Na
+
), 
potassium (K
+
), and calcium (Ca
2+
) are very important for 
the proper functioning of the neuromuscular and 
cardiovascular systems (Guyton and Hall, 2001; Ganong, 
2003). Excessive loss of these ions form the body 
through urine stool or sweat could have serious 
deleterious effects on these two systems likewise their 
excessive retention
 
(Guyton and Hall, 2001; Ganong, 
2003). There is a dearth of information on the influence of 
artemether on the plasma and urine levels of these 
important electrolytes of the body fluid in laboratory 
animals, especially rats. This study was carried out to 
determine the effects of artemether on the plasma and 
urine levels of Na
+
, K
+
, and Ca
2+
 of rats with a view to 
shedding more light on its toxicity in their body fluid and 
renal tissue. 
 
 
MATERIALS AND METHODS 
 
Experimental animals 
 
Eighty adult Wistar rats (200 to 250 g) were used for this study. The 
rats were obtained from the Animal Holding of the Department of 
Physiological Sciences, Obafemi Awolowo University, Ile-Ife, 
Nigeria.  They were kept in the laboratory under natural light/dark 
cycle and were fed on normal mouse cubes (Ladokun feeds, 
Ibadan, Nigeria) and water. The rats were divided into four groups 
labeled I, II, III and IV. Each of the groups consisted of twenty rats, 
ten males and ten females. Each of the rats was housed in a 
separate metabolic cage (Ohaus R Model; Ohaus, Pine Brook, NJ, 
USA) with access to food and water ad libitum. The rats were 
acclimatized for 2 weeks before the commencement of the 
experiments. 
 
 
Drug administration 
 
Injectable form of artemether (80 mg/ml) manufactured by Kunming 
Pharmaceutical Factory, Kunming, People’s Republic of China) was 
dispensed in 1 ml ampoules for intramuscular injection.   
 
 
Dose regimens 
 
Each rat in Group I that weighed 250 g was given 0.16 ml of normal 
saline (equivalent to the volume of the drug that was administered 
to each 250 g rat that received 50.0 mg/kg/day) for 1 week. This 
group served as the control. Each of the rats in Groups II, III and  IV  
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received 12.5, 25.0 and 50.0 mg/kg/day of artemether respectively 
via the intramuscular route for 1 week.  
Urine samples were collected into clean specimen bottles for 24 
h on the day before the commencement of drug administration and 
this was taken as the Day 0 urine for each of the rats. This 
procedure was repeated for Days 3, 7, 11 and 14 of the study, that 
is, one week of drug administration and another one week later. 
The concentrations of Na
+
, K
+
 and Ca
2+
 in the samples were 
measured. The urine concentrations of Na
+
 and K
+
 were determined 
by Flame Photometry using Coming 410C Flame Photometer. The 
Ca
2+
 level was measured using Cresolphthalein Complexone 
method (Burtis and Ashwood, 2001).  
On Day 14, the rats were sacrificed under chloroform anaes-
thesia. A midline incision was made with a surgical blade to expose 
the abdominal organs. Blood was collected from the hearts of the 
rats by cardiac puncture and delivered into lithium heparinized 
specimen bottle. A new syringe was used for the collection of blood 
from each rat; the blood was immediately centrifuged at 3000 
revolutions per minute for 20 min. The plasma was thereafter 
separated into a specimen bottle in readiness for analysis. The 
concentrations of Na
+
, K
+
, and Ca
2+-
 in the samples were 
determined using the same methods that were used in the analysis 
of urine. 
The rats kidneys were dissected out and kept inside 10% 
formalin until their sections were cut and stained with eosin and 
hematoxylin for histological studies. Photomicrographs of the 
tissues were taken using Lect3 Dialux Microscope (Bright Field) at 
×40 magnification. 
 
 
Statistical analysis 
 
The results were expressed as mean ± SEM and subjected to one-
way analysis of variance (ANOVA). Significant differences were 
further tested by the Duncan’s Multiple Range and Student Neuman 
Keuls tests. Student’s t-test was used to compare the urine 
concentration of the electrolyte for each day with the Day 0 value 
for each group. Differences with probability values of p < 0.05 were 
considered significant. 
 
 
RESULTS 
 
Effect of artemether on urine concentration of 
electrolytes 
 
Sodium (Na
+
): Throughout the study, there was no 
significant change in the concentration of Na
+
 in the urine 
of the control rats (Figure 1).  At 12.5 and 25.0 mg/kg, 
urine Na
+
 concentration was significantly higher than the 
Day 0 value and the control rats throughout the study (p < 
0.05), except on Day 7 (at 12.5 mg/kg) and Day 11 (at 
25.0 mg/kg), when it was not significantly different from 
these values. At 50.0 mg/kg, the urine Na
+
 concentration 
decreased gradually and significantly throughout the 
study (p < 0.05).    
 
Potassium (K
+
): The K
+
 concentration in the urine of the 
control rats did not vary significantly throughout the study 
(Figure 2).  At 12.5 mg/kg, K
+
 concentration in the urine 
was significantly higher than that of the control rats and 
that of the Day 0 value throughout the study (p < 0.05).  
At 25.0  mg/kg,  there  was  no  significant  change  in  K
+
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Figure 1. Variation in the urine concentration of sodium due to a week of intramuscular administration of 
artemether to rats. Each point is mean ± SEM (n = 20). *, Significantly different from the Day 0 value (p < 
0.05); a, significantly different from control (NS) (p < 0.05). 
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Figure 2. Variation in the urine concentration of potassium due to a week of intramuscular administration of 
artemether to rats.  Each point is mean ± SEM. (n = 20). *, Significantly different from the Day 0 value (p<0.05). a, 
significantly different from control (NS) (p < 0.05). 
 
 
 
concentration throughout the study. At 50.0 mg/kg, the K
+
 
concentration decreased gradually and significantly 
throughout the study (p<0.05).     
 
Calcium  (Ca
2+
):   No   significant  change  in  urine  Ca
2+
  
concentration was observed in the control rats as well as 
those that received 12.5 and 25.0 mg/kg of artemether, 
throughout the study (Figure 3). At 50.0 mg/kg, urine Ca
2+
 
concentration was significantly reduced throughout the 
study (p < 0.05).  
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Figure 3. Variation in the urine concentration of calcium due to a week of intramuscular administration of 
artemether to rats.  Each point is mean ± SE (n = 20). *, Significantly different from the Day 0 value (p < 
0.05). a, significantly different from control (NS) (p < 0.05) 
 
 
 
DISCUSSION 
 
This study showed a dose-dependent degeneration of the 
renal tissue of the rats under the influence of high doses 
of artemether (Plates 1 to 4). Chemical compounds which 
furnish oxygen based radicals are reputed for their cell 
membrane lipid peroxidation properties.  Lipid 
peroxidation refers to the oxidative degradation of lipids. 
It is the process whereby free radicals take electrons 
away from lipids in cell membranes, resulting in cell 
damage. The endoperoxide bridge in artemether molecule 
produces free radicals which are responsible for the lipid 
peroxidation properties of the drug (Goodman and 
Gilman, 1985; Meshnick, et al., 1991, 1993; Maeno et al., 
1993). The degenerative changes observed in the renal 
tissue of the treated rats could be attributed to the 
destruction of the membrane of the renal tubular cells of 
the rats by the free radicals produced by the drug. 
Analysis of the urine of the rats for electrolytes revealed 
a progressive and significant reduction in the concen-
tration of the electrolytes at 50.0 mg/kg of artemether. 
This indicated that the rats that received this dose of 
artemether produced more dilute urine with each passing 
day of the study, despite the anorexia induced by the 
drug. Inability of the kidney to concentrate or dilute the 
urine is one of the features of damaged nephrons (Leaf 
and Cotran, 1980; Neinman, and Lorenz, 1989; Guyton 
and Hall, 2001; Dunn, 2003; Ganong, 2003). Rapid 
tubular flow occurs in the remaining nephrons of the 
diseased kidneys. The renal tubules lose their ability to 
concentrate or dilute the urine (Guyton and Hall, 2001). 
This study indicated that high doses of artemether are 
toxic to the renal tissue of the rats. We have earlier 
reported a significant increase in the volume of the urine 
produced by rats that received 50.0 mg/kg of artemether, 
during treatment and even one week post-treatment, 
without a corresponding increase in their food and water 
intake for the same period (Akomolafe et. al., 2006). The 
excessive fluid loss of rats that received this dose of 
artemether could lead to dehydration and a severe 
depletion of the major electrolytes of their body fluid. The 
photomicrograph of the kidney of rats that were given this 
dose of artemether showed a very high degree of tissue 
degeneration. The continuous significant decreases in 
the urine concentration of the electrolytes could not have 
been due to increased reabsorption of the electrolytes by 
the renal tubules, but rather to the artemether-induced 
anorexia and the excessive water loss that usually 
accompanies increased electrolyte loss in urine (osmotic 
diuresis). 
Throughout the study, there was no significant change 
in the concentration of Na
+
 in the urine of the control rats 
(Figure 1). This is an indication that the kidney function of 
the rats was not impaired, as evidenced by the photo-
micrograph of their kidneys (Plate 1). At 12.5 and 25.0 
mg/kg, urine Na
+
 concentration was significantly higher 
than the Day 0 and control values throughout the study (p 
< 0.05), except on Day 7 (at 12.5 mg/kg) and Day 11 (at 
25.0 mg/kg),  when it was not significantly different from 
these values. Our  earlier report  indicated  that  rats  that  
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Plate 1: Photomicrograph of the kidney of rats that received normal saline i.m. for 7 days (Control 1 rats). Mag x 400. 
The kidney tissue shows no pathological changes, as reflected by the Bowman’s capsule (B), the glomerulus (G), renal 
tubules (T) and other cells of the renal tissue.  The glomerulus (G) and the capsular space (S) are distinct and intact.  
The tubules retain their normal shapes and the tubular cells have well defined boundaries, and nuclei.  The mesangial 
cells (M) are normal in size shape and number. 
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Plate 2. Photomicrograph of the kidney of  rats that  received 12.5 mg/kg of artemether i.m. for 7 days.  
Mag×400. The glomerulus (G) has expanded to the extent of almost closing the capsular space(S).  The tubular 
cells (C) are densely stained.  The tubules (T) have started losing their integrity as reflected in the distortion of 
their shape. 
 
received 25.0 mg/kg of artemether had significantly 
increased urine output which lasted for even a week after 
treatment, without a corresponding increase in food and 
water intake, most especially during treatment (Akomolafe 
et al., 2006). 
The significant increase in urine Na
+ 
concentration at 
25.0 mg/kg of artemether is an evidence of dehydration 
induced by the drug. The integrity of the nephrons of the 
rats had been severely compromised as revealed by 
Plate 3. The significant increase in urine Na
+
 
concentration at this dose of the drug could also be a 
reflection  of  excessive  sodium  loss  by   the   damaged  
kidneys of the rats. 
The K
+
 concentration in the urine of the control rats did 
not vary significantly throughout the study (Figure 2).  At 
12.5 mg/kg, K
+
 concentration in the urine was significantly 
higher than the control and Day 0 values throughout the 
study (p < 0.05). At 25.0 mg/kg, there was no significant 
change in K
+
 concentration throughout the study. 
Potassium, once absorbed by the intestinal tract, is 
partially removed from the plasma by glomerular filtration 
and is then nearly completely reabsorbed in the proximal 
tubule. Unlike sodium, it is effectively re-excreted by the 
distal tubules There is no  threshold  level  for K
+
 ( Guyton
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Plate 3. Photomicrograph of the kidney of rats that received 25.0 mg/kg of artemether, i.m. for 7 days.  
Mag×400. The Bowman’s capsule (B) started breaking down. The glomerulus (G) has undergone 
degeneration.  The capsular space (C) has been completely obliterated.  The tubular cells (S) are still 
densely stained.  The tubules (T) have lost much of their integrity as their boundaries are no more well 
defined.  The intertubular space (P) are almost completely closed due to inflammation of the tubules.  
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Plate 4.Photomicrograph of the kidney of rats that received 50.0 mg/kg of artemether i.m. for 7 days. Mag×400. The 
Bowman capsule (B) is almost non-existent due to degeneration.  The densely stained tubular cells (C) are still 
observable, though the tubular intergrity (T) has been grossly distorted as a result of inflammation and degenerative 
changes. 
 
 
and 25.0mg/kg of artemether in this study could be 
attributed to the differences in the renal handling of the 
two electrolytes. Potassium is mainly an intracellular 
electrolyte. The damaged renal tissue could also be a 
source for additional K
+
 in the body fluid of the rats. 
Artemether caused no significant change in urine Ca
2+
 
concentration in the control rats as well as those that 
received 12.5 and 25.0 mg/kg of artemether, throughout 
the study (Figure 3). It could be due to the fact that 
artemether does not have any appreciable effects on 
renal Ca2
+
 excretion at these doses of the drug. 
However, this needs further verification. 
The plasma Na
+ 
concentration was significantly increa-
sed at 25.0 mg/kg of artemether only (p < 0.05) (Figure 
4). This is in conformity with the observed significant 
elevation of the urine concentration of this electrolyte in 
rats that received this dose of artemether. The 
significantly increased Na
+
 concentration in the plasma of 
rats that received 25.0 mg/kg of the drug could be due to 
the same reasons given for the elevated urine level of the 
electrolyte. The reductions observed at 12.5 and 50.0 
mg/kg of the drug were not significant. The plasma K
+ 
concentration increased significantly at all the doses of 
artemether studied, except at 50.0 mg/kg where it was 
significantly reduced (Figure 5). The significant increase 
in the plasma concentrations of this electrolyte at lower 
doses of artemether could be as a result of the drug-
induced renal tissue damage at these doses, while the
4232        Afr. J. Biotechnol. 
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Figure 4. Effect of artemether on the plasma sodium concentration of rats. *Significantly different 
from control (p < 0.05). The plasma Na
+ 
concentration was significantly increased at 25.0 mg/kg of 
artemether only (p < 0.05). The reduction observed at 12.5 and 50.0 mg/kg of the drug was not 
significant. 
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Figure 5. Effect of artemether on the plasma potassium concentration of rats. *Significantly different from control (p < 
0.05). The plasma K
+ 
concentration increased significantly at all the doses of artemether studied, except at 50.0 mg/kg 
where it was significantly reduced. 
 
 
 
significant decrease at 50.0 mg/kg could be attributed to 
the earlier reported sustained significant reduction in food 
consumption, increased urine output, as well as much 
degeneration of the nephrons induced by artemether. 
There was no significant difference in the plasma Ca
2+ 
level of the control rats and those that received 12.5 and 
25.0 mg/kg of artemether (Figure 6). This is an indication 
that, at these doses of artemether, calcium excretion was 
not adversely affected by the renal tubular damage 
induced by the drug. However, a significant decrease in 
the plasma level of this electrolyte was observed at 50.0 
mg/kg of the drug.  
 
 
Conclusion 
 
High doses of artemether caused progressive dege-
neration of the renal tissue, inability of the nephrons to 
concentrate urine, excessive water loss and electrolyte 
depletion in rats. 
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Figure 6. Effect of artemether on the plasma calcium concentration of rats. *Significantly different from control (p < 0.05). 
There was no significant difference in the plasma Ca
2+ 
level of the control rats and those that received 12.5 and 25.0 mg/kg 
of artemether. At 50.0 mg/kg, plasma Ca
2+
 decreased significantly. 
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